1-5 of 5
Xiaodong Shi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Homoharringtonine-Based Induction Regimens Combined with ATRA-Based Maintenance in Chinese Pediatric AML: A Report from the Cclg-AML 2015 Protocol Study

Jing Li, Ju Gao, Ansheng Liu, Wei Liu, Hao Xiong, Changda Liang, Yongjun Fang, Yunpeng Dai, Jingbo Shao, Hui Yu, Lingzhen Wang, Li Wang, Liangchun Yang, Mei Yan, Xiaowen Zhai, Xiaodong Shi, Xin Tian, Xiuli Ju, Yan Chen, Jing Wang, Leping Zhang, Hui Liang, Sen Chen, Jingrong Zhang, Haixia Cao, Jiao Jin, Qun Hu, Junlan Wang, Yilin Wang, Min Zhou, Yueqin Han, Rong Zhang, Weihong Zhao, Aimin Li, Limin Lin, Ruidong Zhang, Chao Gao, Liting Xu, Yuanyuan Zhang, Jia Fan, Ying Wu, Wei Lin, Jiaole Yu, Peijing Qi, Pengli Huang, Xiaoxia Peng, Yaguang Peng, Huyong Zheng
Journal: Blood
Blood (2022) 140 (Supplement 1): 3189–3191.
https://doi.org/10.1182/blood-2022-165737
Published: 2022
Journal Articles

A Multicenter Randomized Non-Inferiority Study of Homoharringtonine Versus Etoposide in Induction Phase for Chinese Childhood Acute Myeloid Leukemia - a Report from China Children's Leukemia Group (CCLG)

Jing Li, PhD, Jiaole Yu, PhD MD, Ruidong Zhang, MD PhD, Ju Gao, PhD, Changda Liang, MD PhD, Ansheng Liu, Wei Liu, Lijun Qu, Yufeng Liu, Hongsheng Wang, MD, Minghua Yang, MD, Yunpeng Dai, PhD, Hui Jiang, PhD, Yongjun Fang, PhD, Lirong SUN, PhD, Xiuli Ju, Xin Tian, PhD, Jianxin Li, Xiaodong Shi, MD, Li Wang, Leping Zhang, PhD, Runming Jin, MD, Yan Chen, MD, Guoping Hao, MD, Mei Yan, MD, Hui Liang, Cuimin Zheng, Sen Chen, Jingrong Zhang, Haixia Cao, Kaili Pan, PhD, Qun Hu, MD PhD, Zhixu He, MD, Min Zhou, Weihong Zhao, PhD, Yilin Wang, Rong Zhang, MDand PhD, Yueqin Han, Aimin Li, Huyong Zheng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1356.
https://doi.org/10.1182/blood-2019-127932
Published: 2019
Journal Articles

Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China

Lihua Yang, MDPhD, Xiaoli Ma, MDPhD, Yu-Chen Liu, MSc, Wen Zhao, MDPhD, Lihua Yu, PhD, Maoquan Qin, MDPhD, Guanghua Zhu, MDPhD, Kai Wang, MDPhD, Xiaodong Shi, MD, Zhaoxia Zhang, MD, Jingfu Wang, MD, Yuan Sun, MD, Lujia Dong, MD, Shih-Ting Tsao, MSc, Rui Zhang, MSc, Lung-Ji Chang, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3335.
https://doi.org/10.1182/blood.V130.Suppl_1.3335.3335
Published: 2017
Journal Articles

Knock-in of Dnmt3a R878H Recapitulates Human Acute Myeloid Leukemia Harboring DNMT3A Mutation and Is Highly Responsive to mTOR Inhibitor Rapamycin

Yujun Dai, Yueying Wang, Jinyan Huang, Li Xia, Xiaodong Shi, Sai-Juan Chen, Zhu Chen
Journal: Blood
Blood (2016) 128 (22): 2836.
https://doi.org/10.1182/blood.V128.22.2836.2836
Published: 2016
Journal Articles

Absolute Lymphocyte Counts Refine MRD-Based Risk Stratification in Pediatric ALL.

Rabin R. Rabin, MD, M. Monica Gramatges, MD, Michael J. Borowitz, MD/PhD, Shana L Palla, MS, Xiaodong Shi, MD, Judith F Margolin, MD, Patrick A. Zweidler-McKay, MD/PhD
Journal: Blood
Blood (2009) 114 (22): 1593.
https://doi.org/10.1182/blood.V114.22.1593.1593
Published: 2009